PC_017 Determinants of Non-Participation in Cervical Cancer Screening by Human Papilloma Virus Self-Sampling among Urban Women in Mumbai, India.

S. Pimple (1), D. Thiruvengadam (2), G. Mishra (3), A. Maheshwari (4), S. Biswas (4), K. Prasad (5)
(1) Head Of The Department Of Preventive Oncology, Tmh, Mumbai, Mumbai, Inde, (2) Fellow 2, Preventive Oncology, Tmh, Mumbai, Mumbai, Inde, (3) Professor, Department Of Preventive Oncology, Tata Memorial Hospital, Mumbai, Mumbai, Inde, (4) Head Of Department Of Gynec-Oncology Tmh, Mumbai, Mumbai, Inde, (5) Director, Manipal School Of Information Sciences, Mahe, Manipal, Inde

PC_019 Psychological Parameters in Individuals with a Positive HPV Test and Normal Cytology (Pap I or IIa) Compared to Individuals with a Negative or Unknown HPV Status (HAPPI study)

W. Reents (1), A. Hildebrandt (1), M. Schild-Suhren (2), A. Lindig (1)
(1) Department Of Psychology, Faculty Of Medicine And Health Sciences, University Medicine Oldenburg, Carl Von Ossietzky Universität Oldenburg, Oldenburg, Allemagne, (2) Cervical Dysplasia Unit, Department Of Gynecology, Faculty Of Medicine And Health Sciences, University Medicine Oldenburg, Klinikum Oldenburg, Oldenburg, Allemagne

PC_003 Turning Awareness in Action: Understanding Facilitators and Barriers to Cervical Cancer Screening, Insights from the CASCADE “CN001” Study

K. Lymon (1), M.G. Tadros (1), K. Cho (1), L. Flowers (1), C. Mehta (2), N. Kaonga (1), L. Gaydos (3), A. Sheth (4), M.L.T. Nguyen (2), V. Sahasrabudhe (5)
(1) Department Of Obstetrics And Gynecology, School Of Medicine, Emory University, Atlanta, États-Unis, (2) Emory University, Atlanta, États-Unis, (3) Department Of Health Policy And Management, Emory University, Atlanta, États-Unis, (4) Department Of Infectious Disease, School Of Medicine, Emory University, Atlanta, États-Unis, (5) Division Of Cancer Prevention, National Cancer Institute, National Institutes Of Health (nih), Rockville, Md, États-Unis